Wednesday, October 22, 2003

Mormon Temple, Salt Lake City

A Randomized Trial of High and Low Source Strength I-125 Prostate Seed Implants Presenter: Vrinda Narayana, MDPresenter's Affiliation: University of MichiganType of Session: ScientificBackground Prostate brachytherapy is an established treatment modality for early, localized adenocarcinoma of the prostate. Selected patients with...
Amifostine As Mucosal Protectant in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Intensive Chemotherapy and Thoracic Radiotherapy (RT): Results of the Radiation Therapy Oncology Group (RTOG) 98-01 Study Presenter: Maria Werner-Wasik, MDPresenter's Affiliation: Thomas Jefferson UniversityType of Session: ScientificBackground 20-50% of patients receiving thoracic RT with concurrent chemotherapy experience severe esophagitis. Amifostine (AMI) is a...
Analysis of Local Failure After Breast Conserving Therapy for Locally Advanced Breast Cancer Presenter: Eugenio F. Vines, MDPresenter's Affiliation: Instituto de Radiomedicina, Santiago, ChileType of Session: ScientificBackground Locally advanced breast cancer remains a large problem in developing countries. The standard treatment for LABC...
Changes of Tumor Motion Patterns During a Course of Radiation Therapy for Lung Cancer Presenter: Kenneth M. Forster, PhDPresenter's Affiliation: MD Anderson Cancer Center, Houston, TXType of Session: ScientificBackground Patient and target immobilization with daily reproducibility are the cornerstones of accurate and precise radiation...
Economic Issues in 3DCRT and IMRT Moderator: Theodore L. Phillips, MD., University of California, San Francisco Jeffrey M. Michalski, MD, MBA, Washington University, St. Louis There are several key questions regarding a treatment when performing an economic analysis: Can...
Geometrical Uncertainties and Inverse Treatment Planning for IMRT: An Integrated Approach Instead of Using Planning Margins Presenter: Ben J. HeijmenPresenter's Affiliation: Daniel den Hoed Cancer Center, Rotterdam, The NetherlandsType of Session: ScientificBackground The current approach to IMRT involves a planning treatment volume (PTV)-based approach, which places a...
IMRT for Head and Neck Cancer: Updated Clinical Results Moderator: Theodore L. Phillips, MD., University of California, San Francisco Nancy Lee, MD, Memorial Sloan-Kettering Cancer Center, New York Approximately 150 papers have reported on the outcomes of H&N cancer patients treated with IMRT. ...
IMRT-Physics Aspects Moderator: Theodore L. Phillips, MD., University of California, San Francisco Lynn J. Verhey, PhD., University of California, San Francisco IMRT is now commonly used for patient treatment. Compared to 3D conformal treatment (3DCRT), IMRT...
IMRT: Another Point of View Moderator: Theodore L. Phillips, MD., University of California, San Francisco Edward C. Halperin, MD, Duke University There is a difference between research and therapy. As a field, we have used research and randomized trials selectively if...
Randomized Trials and IMRT: Overkill or Overdue? Moderator: Theodore L. Phillips, MD., University of California, San Francisco Soeren M. Bentzen, PhD., DSc., Gray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom IMRT is an advanced technology for...
The Role of Prophylactic Tamsulosin (Flomax) in Patients Undergoing Prostate 125-I Seed Implants for Prostate Carcinoma: Final Report of a Double-Blind Placebo-Controlled Randomized Study Presenter: Mohamed Elshaikh, MDPresenter's Affiliation: Cleveland Clinic FoundationType of Session: ScientificBackground Urinary morbidity following radioactive seed implantation for prostate cancer is common. Alpha-blockers with or without steroids...